ClinicalTrials.gg
TerminatedNCT03056508LEADUpdated Oct 14, 2020

Lifestyle, Exercise and Diet: The LEAD Study

An interventional study of Exercise plus nutrition and Exercise in Subjective Cognitive Decline and Age-Related Cognitive Decline, sponsored by Rotman Research Institute at Baycrest. Terminated at 4 sites in Canada. Open to participants aged 60 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-10-14.

Sponsored by Rotman Research Institute at Baycrest · Not applicable, Interventional, and Prevention

How we know

Why this study was terminated
Due to COVID-19, recruitment and enrollment was suspended and never resumed. COVID-related changes have been made to the clinical program which houses our intervention, and we could not compare new participants with our previous cohort.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
60 Years to 85 Years
Sex
All
01

Study summary

This study will explore the impact of an exercise and nutrition (EX+NUTR) , relative to exercise alone (EX) intervention, on brain structure and function as well as blood biomarkers in older adults with subjective cognitive decline (SCD) and vascular risk factors. The overall hypotheses are that a combined EX+NUTR, relative to EX, intervention will evoke more positive changes in brain structure (e.g. hippocampal volume), neural activity (e.g. task associated functional activations monitored through fMRI), and cognitive performance. These changes will be associated with an improved metabolic profile, reductions in inflammatory cytokines and oxidative burden, and greater intervention compliance.

Read the detailed description

All participants will engage in group supervised exercise sessions once per week as well as engage in additional exercise sessions at home 4 days/week. The exercise program will be run out of two sites (Toronto Rehabilitation Institute (TRI) - Rumsey Centre in Toronto, and the Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo). The supervised exercise sessions modeled after the standard TRI Cardiovascular Prevention and Rehabilitation program, including aerobic training, resistance training and education/counseling. The active group will receive strategy training to simultaneously improve their diet in conjunction with our newly developed Brain Health Food Guide (EX+BHFG); the placebo control group (EX+BHEd) will receive brain health education to control for time and social participation. [NOTE All participants must also be enrolled in the SCD cohort of the CCNA and undergo the CCNA's COMPASS-ND assessment at the beginning of the trial.] The study is 6 months in duration and requires participants to attend 2.5 hr weekly sessions (1 hr supervised exercise, 0.5 hr exercise/stress education and 1 hr nutrition or brain health education) and to exercise on their own an additional 3-4 times per week. Participants are assessed on measures of cognition, brain health (MRI), functional status at baseline, post intervention and 6 month follow-up.

02

Conditions studied

  • Subjective Cognitive Decline
  • Age-Related Cognitive Decline

Keywords

  • diet
  • nutrition
  • aerobic exercise
  • cognition
  • grey matter
  • cerebral blood flow
  • neural activity
  • resting state connectivity
03

In context

Lead sponsor

Rotman Research Institute at Baycrest is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • meeting criteria for subjective cognitive impairment (1 through 5 below)

    1. Answer Yes to both following questions:

      1. Do you feel like your memory or thinking is becoming worse?
      2. Does this concern you?
    2. Have a delayed recall score on 1 paragraph of the Logical Memory test (Wechsler Memory Scale, maximum score 25) above the education-adjusted cut-offs:

      • ≥9 for 16+ years of education;
      • ≥5 for 8-15 years of education;
      • ≥3 for 0-7 years of education.
    3. Have a (MoCA) total score of 20 and over (≥20/30).
    4. Have a delayed recall score on the CERAD word list of 5 and over (≥5).
    5. Have a global Clinical Dementia Rating score (CDR) equal to 0.5 or less (≤0.5).
  • ≥2 vascular risk factors (overweight (>25), T2DM, hypercholesterolemia or hypertension),
  • Consuming a poor quality diet (at least median or below on number of servings of vegetable, fruit, fish and nuts based on Canadian consumption patterns in older adults)
  • Reasonably sedentary (less than 75min per week of moderate - vigorous intensity physical activity)
  • Be available for the whole intervention (6 months) and a 12- month follow-up visit
  • English speaking

Exclusion criteria

Exclusion Criteria:

  • The presence of significant known chronic brain disease such as: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, malignant tumors, Parkinson's disease, and other rarer brain illnesses.
  • Ongoing alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures.
  • Subject does not have a study partner who can provide corroborative information.
  • Symptomatic stroke within the previous year.
  • Unable to undergo MRI scan due to medical or inability to tolerate the procedure.
  • Major surgery within last 2 months.
  • History of intracranial surgery
  • Serious comorbid condition that, in the opinion of the study investigator, is likely to result in death within a year.
  • High performance athletes
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Exercise plus Nutrition

    6 months of supervised group exercise plus education and strategy training to alter diet to be consistent with recommendations outlined in our brain health food guide (BHFG).

    Behavioral: Exercise plus nutrition

  • Active comparator
    Exercise

    Identical exercise to the experimental plus education and passive discussion about brain health and healthy lifestyle to control for experimental group nutrition sessions.

    Behavioral: Exercise

Interventions

  • BehavioralExercise plus nutrition

    On the same day as the exercise class, participants will also receive nutrition support. Participants will alter their overall diet to be consistent with recommendations outlined in our brain health food guide (BHFG) and receive diet counseling and strategy training to promote retention and enable this dietary change. For the first two months, diet group sessions will be held on a weekly basis. For the remaining four months, sessions will be divided between group sessions and individual meetings with study dietitians, on a predefined schedule. Participants will submit weekly logs outlining diet goals, plans, successes and obstacles to help direct identification of sequential goals.

  • BehavioralExercise

    Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise (4 additional aerobic and 2-3 resistance training sessions per week) will be monitored by an exercise diary. The initial walking prescription will be set at \~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% VO2-peak. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of VO2-peak and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.

06

What researchers measure

Primary outcomes

  1. Changes from baseline brain structure at 6 months and 12 months.

    Cortical and subcortical grey matter density using MRI three-dimensional T1 weighted structural scan (MPRAGE)

    Time frame: 6 months plus 6 month follow-up

Secondary outcomes

  1. Changes from baseline cerebral blood flow at 6 months and 12 months.

    Pseudo-continuous arterial spin labeling MRI (pcASL) to quantify cerebral blood flow

    Time frame: 6 months plus 6 month follow-up

  2. Changes from baseline cognition at 6 months and 12 months

    pen and paper and computerized tasks, monitoring memory, executive function, and speed of processing. The results will be presented as a composite score of total neuro-psychological performance aggregating scores from the above cognitive domains.

    Time frame: 6 months plus 6 month follow-up

  3. Changes from baseline brain activity related to attention at 6 months and 12 months

    BOLD functional MRI while participants performing an attention task

    Time frame: 6 months plus 6 month follow-up

  4. Changes from baseline resting state connectivity at 6 months and 12 months

    BOLD functional MRI while participants at rest

    Time frame: 6 months plus 6 month follow-up

  5. Changes from baseline diet quality at 6 months and 12 months

    Principle component analyses based on Canadian Diet History Questionnaire II (C-DHQII)

    Time frame: 6 months plus 6 month follow-up

  6. Changes from baseline adherence to diet recommendations at 6 months and 12 months

    Principle component analyses based on the Eating Pattern Self-Assessment

    Time frame: 6 months plus 6 month follow-up

  7. Changes from baseline grip strength at 6 months and 12 months

    Grip strength using a hand held dynamometer

    Time frame: 6 months plus 6 month follow-up

  8. Changes from baseline gait performance at 6 months and 12 months

    Gait velocity, stride length/width, and associated variability assessed using a GAITRite pressure sensor mat.

    Time frame: 6 months plus 6 month follow-up

  9. Changes from baseline balance performance at 6 months and 12 months

    Posturography assessment on balance platform

    Time frame: 6 months plus 6 month follow-up

  10. Changes from baseline maximal oxygen uptake at 6 months and 12 months

    VO2max determined during cardiopulmonary assessment

    Time frame: 6 months plus 6 month follow-up

  11. Changes from baseline blood moderators at 6 months and 12 months

    e.g. BDNF, pro-BDNF, ApoE,

    Time frame: 6 months plus 6 month follow-up

  12. Changes from baseline HbA1C at 6 months and 12 months

    HbA1C

    Time frame: 6 months plus 6 month follow-up

  13. Changes from baseline fasting glucose at 6 months and 12 months

    fasting glucose

    Time frame: 6 months plus 6 month follow-up

  14. Changes from baseline insulin levels at 6 months and 12 months

    insulin

    Time frame: 6 months plus 6 month follow-up

  15. Changes from baseline lipid levels at 6 months and 12 months

    lipid profile

    Time frame: 6 months plus 6 month follow-up

  16. Changes from baseline homocysteine levels at 6 months and 12 months

    homocysteine

    Time frame: 6 months plus 6 month follow-up

  17. Changes from baseline C reactive protein levels at 6 months and 12 months

    CRP

    Time frame: 6 months plus 6 month follow-up

  18. Changes from baseline TNF-alpha levels at 6 months and 12 months

    TNF-alpha

    Time frame: 6 months plus 6 month follow-up

  19. Changes from baseline IL6 levels at 6 months and 12 months

    IL6

    Time frame: 6 months plus 6 month follow-up

  20. Changes from baseline vitamin K levels at 6 months and 12 months

    Vitamin K

    Time frame: 6 months plus 6 month follow-up

07

Study locations

4 sites
  • Toronto Rehabilitation Institute Rumsey Centre
    Toronto, Ontario M4G 2V6, Canada
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario M4N 3M5, Canada
  • Rotman Research Institute
    Toronto, Ontario M6A 2E1, Canada
  • Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo
    Waterloo, Ontario, Canada
08

References and documents

Publications

  • Koblinsky ND, Anderson ND, Ajwani F, Parrott MD, Dawson D, Marzolini S, Oh P, MacIntosh B, Middleton L, Ferland G, Greenwood CE. Feasibility and preliminary efficacy of the LEAD trial: a cluster randomized controlled lifestyle intervention to improve hippocampal volume in older adults at-risk for dementia. Pilot Feasibility Stud. 2022 Feb 9;8(1):37. doi: 10.1186/s40814-022-00977-6. PubMed 35139918 ↗

Individual participant data

Plan to share: Yes — data will be uploaded to shared CCNA database - LORIS

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2018 to primary completion in Oct 2020, 27 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2017
First posted
Feb 17, 2017
StartActual
Jul 1, 2018
Primary completionActual
Oct 8, 2020
CompletionActual
Oct 8, 2020
Last update
Oct 14, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03056508
Lead sponsor
Rotman Research Institute at Baycrest
Collaborators
Sunnybrook Health Sciences Centre, Toronto Rehabilitation Institute, The Centre for Memory and Aging, University of Waterloo
Responsible party
Carol Greenwood (Senior Scientist, Rotman Research Institute at Baycrest) — Principal investigator
First posted
Feb 17, 2017
Start date
Jul 1, 2018
Primary completion
Oct 8, 2020
Completion
Oct 8, 2020
Last update
Oct 14, 2020

Study contacts

Carol E Greenwood, PhD
principal investigator · Rotman Research Institute Baycrest Health Sciences
Nicole D Anderson, PhD
principal investigator · Rotman Research Institute Baycrest Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion